Abstract
Infectious biofilms are difficult to target with conventional antibiotherapy due to their intrinsic tolerance to antibiotics. In vitro, ex vivo and in vivo studies have shown great efficacy of bacteriophages (phages) in combating biofilms. However, the tri-dimensional organisation of the biofilm cells inside a polymeric matrix, along with their sessile associated physiology, imposes some difficulties to phage therapy. Phage–biofilm interactions are highly dependent on the biofilm structure and physiology and therefore greatly influenced by the models used to grow biofilms. In this chapter, the challenges faced by phages when interacting and kill biofilm cells will be discussed as well as the methods used to study phage–biofilm interactions. Approaches to enhance phage efficacy towards infectious biofilms will also be addressed in this chapter.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1(2):66–85. https://doi.org/10.4161/bact.1.2.15845
Allers E, Moraru C, Duhaime MB, Beneze E, Solonenko N, Barrero-Canosa J, Amann R, Sullivan MB (2013) Single-cell and population level viral infection dynamics revealed by phage FISH, a method to visualize intracellular and free viruses. Environ Microbiol 15(8):2306–2318. https://doi.org/10.1111/1462-2920.12100
Alves DR, Gaudion A, Bean JE, Perez Esteban P, Arnot TC, Harper DR, Kot W, Hansen LH, Enright MC, Jenkins AT (2014) Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation. Appl Environ Microbiol 80(21):6694–6703. https://doi.org/10.1128/aem.01789-14
Alves DR, Booth SP, Scavone P, Schellenberger P, Salvage J, Dedi C, Thet NT, Jenkins ATA, Waters R, Ng KW, Overall ADJ, Metcalfe AD, Nzakizwanayo J, Jones BV (2018) Development of a high-throughput ex-vivo burn wound model using porcine skin, and its application to evaluate new approaches to control wound infection. Front Cell Infect Microbiol 8:196. https://doi.org/10.3389/fcimb.2018.00196
Arciola CR, Campoccia D, Montanaro L (2018) Implant infections: adhesion, biofilm formation and immune evasion. Nat Rev Microbiol 16(7):397–409. https://doi.org/10.1038/s41579-018-0019-y
Azeredo J, Azevedo NF, Briandet R, Cerca N, Coenye T, Costa AR, Desvaux M, Di Bonaventura G, Hebraud M, Jaglic Z, Kacaniova M, Knochel S, Lourenco A, Mergulhao F, Meyer RL, Nychas G, Simoes M, Tresse O, Sternberg C (2017) Critical review on biofilm methods. Crit Rev Microbiol 43(3):313–351. https://doi.org/10.1080/1040841X.2016.1208146
Basu S, Agarwal M, Kumar Bhartiya S, Nath G, Kumar Shukla V (2015) An in vivo wound model utilizing bacteriophage therapy of Pseudomonas aeruginosa biofilms. Ostomy Wound Manage 61(8):16–23
Bedi MS, Verma V, Chhibber S (2009) Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B 5055. World J Microbiol Biotechnol 25(7):1145. https://doi.org/10.1007/s11274-009-9991-8
Bjarnsholt T, Alhede M, Alhede M, Eickhardt-Sorensen SR, Moser C, Kuhl M, Jensen PO, Hoiby N (2013) The in vivo biofilm. Trends Microbiol 21(9):466–474. https://doi.org/10.1016/j.tim.2013.06.002
Brackman G, Coenye T (2016) In vitro and in vivo biofilm wound models and their application. Adv Exp Med Biol 897:15–32. https://doi.org/10.1007/5584_2015_5002
Carson L, Gorman SP, Gilmore BF (2010) The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol Med Microbiol 59(3):447–455. https://doi.org/10.1111/j.1574-695X.2010.00696.x
Cerca F, Trigo G, Correia A, Cerca N, Azeredo J, Vilanova M (2011) SYBR green as a fluorescent probe to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can J Microbiol 57(10):850–856. https://doi.org/10.1139/w11-078
Ceri H, Olson ME, Stremick C, Read RR, Morck D, Buret A (1999) The calgary biofilm device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37(6):1771–1776
Chaudhry WN, Concepcion-Acevedo J, Park T, Andleeb S, Bull JJ, Levin BR (2017) Synergy and order effects of antibiotics and phages in killing Pseudomonas aeruginosa biofilms. PLoS One 12(1):e0168615. https://doi.org/10.1371/journal.pone.0168615
Chylkova T, Cadena M, Ferreiro A, Pitesky M (2017) Susceptibility of Salmonella biofilm and planktonic bacteria to common disinfectant agents used in poultry processing. J Food Prot 80(7):1072–1079. https://doi.org/10.4315/0362-028x.jfp-16-393
Coulter LB, McLean RJ, Rohde RE, Aron GM (2014) Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses 6(10):3778–3786. https://doi.org/10.3390/v6103778
Curtin JJ, Donlan RM (2006) Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob Agents Chemother 50(4):1268–1275. https://doi.org/10.1128/aac.50.4.1268-1275.2006
Dalmasso M, de Haas E, Neve H, Strain R, Cousin FJ, Stockdale SR, Ross RP, Hill C (2015) Isolation of a novel phage with activity against Streptococcus mutans biofilms. PLoS One 10(9):e0138651. https://doi.org/10.1371/journal.pone.0138651
Donlan RM (2009) Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17(2):66–72. https://doi.org/10.1016/j.tim.2008.11.002
Drilling A, Morales S, Boase S, Jervis-Bardy J, James C, Jardeleza C, Tan NC, Cleland E, Speck P, Vreugde S, Wormald PJ (2014) Safety and efficacy of topical bacteriophage and ethylenediaminetetraacetic acid treatment of Staphylococcus aureus infection in a sheep model of sinusitis. Int Forum Allergy Rhinol 4(3):176–186. https://doi.org/10.1002/alr.21270
Dubrovin EV, Popova AV, Kraevskiy SV, Ignatov SG, Ignatyuk TE, Yaminsky IV, Volozhantsev NV (2012) Atomic force microscopy analysis of the Acinetobacter baumannii bacteriophage AP22 lytic cycle. PLoS One 7(10):e47348. https://doi.org/10.1371/journal.pone.0047348
Forti F, Roach DR, Cafora M, Pasini ME, Horner DS, Fiscarelli EV, Rossitto M, Cariani L, Briani F (2018) Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob Agents Chemother 62(6). https://doi.org/10.1128/aac.02573-17
Fu W, Forster T, Mayer O, Curtin JJ, Lehman SM, Donlan RM (2010) Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother 54(1):397–404. https://doi.org/10.1128/aac.00669-09
Gonzalez S, Fernandez L, Gutierrez D, Campelo AB, Rodriguez A, Garcia P (2018) Analysis of different parameters affecting diffusion, propagation and survival of staphylophages in bacterial biofilms. Front Microbiol 9:2348. https://doi.org/10.3389/fmicb.2018.02348
Gutierrez D, Hidalgo-Cantabrana C, Rodriguez A, Garcia P, Ruas-Madiedo P (2016) Monitoring in real time the formation and removal of biofilms from clinical related pathogens using an impedance-based technology. PLoS One 11(10):e0163966. https://doi.org/10.1371/journal.pone.0163966
Hall CW, Mah TF (2017) Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev 41(3):276–301. https://doi.org/10.1093/femsre/fux010
Henry M, Lavigne R, Debarbieux L (2013) Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections. Antimicrob Agents Chemother 57(12):5961–5968. https://doi.org/10.1128/AAC.01596-13
Hoiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35(4):322–332. https://doi.org/10.1016/j.ijantimicag.2009.12.011
Holguin AV, Rangel G, Clavijo V, Prada C, Mantilla M, Gomez MC, Kutter E, Taylor C, Fineran PC, Barrios AF, Vives MJ (2015) Phage Phi Pan70, a putative temperate phage, controls Pseudomonas aeruginosa in planktonic, biofilm and burn mouse model assays. Viruses 7(8):4602–4623. https://doi.org/10.3390/v7082835
Jault P, Leclerc T, Jennes S, Pirnay JP, Que YA, Resch G, Rousseau AF, Ravat F, Carsin H, Le Floch R, Schaal JV, Soler C, Fevre C, Arnaud I, Bretaudeau L, Gabard J (2019) Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect Dis 19(1):35–45. https://doi.org/10.1016/S1473-3099(18)30482-1
Kelly D, McAuliffe O, Ross RP, O'Mahony J, Coffey A (2011) Development of a broad-host-range phage cocktail for biocontrol. Bioeng Bugs 2(1):31–37. https://doi.org/10.4161/bbug.2.1.13657
Kelly D, McAuliffe O, Ross RP, Coffey A (2012) Prevention of Staphylococcus aureus biofilm formation and reduction in established biofilm density using a combination of phage K and modified derivatives. Lett Appl Microbiol 54(4):286–291. https://doi.org/10.1111/j.1472-765X.2012.03205.x
Khalifa L, Brosh Y, Gelman D, Coppenhagen-Glazer S, Beyth S, Poradosu-Cohen R, Que YA, Beyth N, Hazan R (2015) Targeting Enterococcus faecalis biofilms with phage therapy. Appl Environ Microbiol 81(8):2696–2705. https://doi.org/10.1128/AEM.00096-15
Kim S, Rahman M, Seol SY, Yoon SS, Kim J (2012) Pseudomonas aeruginosa bacteriophage PA1O requires type IV pili for infection and shows broad bactericidal and biofilm removal activities. Appl Environ Microbiol 78(17):6380–6385. https://doi.org/10.1128/AEM.00648-12
Kutter E, De Vos D, Gvasalia G, Alavidze Z, Gogokhia L, Kuhl S, Abedon ST (2010) Phage therapy in clinical practice: treatment of human infections. Curr Pharm Biotechnol 11(1):69–86
Latz S, Kruttgen A, Hafner H, Buhl EM, Ritter K, Horz HP (2017) Differential effect of newly isolated phages belonging to PB1-like, phiKZ-like and LUZ24-like viruses against multi-drug resistant Pseudomonas aeruginosa under varying growth conditions. Viruses 9(11). https://doi.org/10.3390/v9110315
Lebeaux D, Chauhan A, Rendueles O, Beloin C (2013) From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens 2(2):288–356. https://doi.org/10.3390/pathogens2020288
Liu Y, Mi Z, Niu W, An X, Yuan X, Liu H, Wang Y, Feng Y, Huang Y, Zhang X, Zhang Z, Fan H, Peng F, Li P, Tong Y, Bai C (2016) Potential of a lytic bacteriophage to disrupt Acinetobacter baumannii biofilms in vitro. Future Microbiol 11:1383–1393. https://doi.org/10.2217/fmb-2016-0104
McVay CS, Velasquez M, Fralick JA (2007) Phage therapy of Pseudomonas aeruginosa infection in a mouse burn wound model. Antimicrob Agents Chemother 51(6):1934–1938. https://doi.org/10.1128/AAC.01028-06
Melo LD, Veiga P, Cerca N, Kropinski AM, Almeida C, Azeredo J, Sillankorva S (2016) Development of a phage cocktail to control Proteus mirabilis catheter-associated urinary tract infections. Front Microbiol 7:1024. https://doi.org/10.3389/fmicb.2016.01024
Melo LDR, Franca A, Brandao A, Sillankorva S, Cerca N, Azeredo J (2018) Assessment of Sep1virus interaction with stationary cultures by transcriptional and flow cytometry studies. FEMS Microbiol Ecol 94(10). https://doi.org/10.1093/femsec/fiy143
Mendes JJ, Leandro C, Corte-Real S, Barbosa R, Cavaco-Silva P, Melo-Cristino J, Gorski A, Garcia M (2013) Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen 21(4):595–603. https://doi.org/10.1111/wrr.12056
Mendes JJ, Leandro C, Mottola C, Barbosa R, Silva FA, Oliveira M, Vilela CL, Melo-Cristino J, Gorski A, Pimentel M, Sao-Jose C, Cavaco-Silva P, Garcia M (2014) In vitro design of a novel lytic bacteriophage cocktail with therapeutic potential against organisms causing diabetic foot infections. J Med Microbiol 63(Pt 8):1055–1065. https://doi.org/10.1099/jmm.0.071753-0
Milho C, Silva MD, Melo L, Santos S, Azeredo J, Sillankorva S (2018) Control of Salmonella Enteritidis on food contact surfaces with bacteriophage PVP-SE2. Biofouling:1–16. https://doi.org/10.1080/08927014.2018.1501475
Milho C, Andrade M, Vilas Boas D, Alves D, Sillankorva S (2019) Antimicrobial assessment of phage therapy using a porcine model of biofilm infection. Int J Pharm 557:112–123. https://doi.org/10.1016/j.ijpharm.2018.12.004
Montanez-Izquiredo VY, Salas-Vazquez DI, Rodriguez JJ (2012) Use of epifluorescence microscopy to assess the effectiveness of phage P100 in controlling Listeria monocytogenes biofilms on stainless steel surfaces. Food Control 23(2):470–477
Nakai T, Park SC (2002) Bacteriophage therapy of infectious diseases in aquaculture. Res Microbiol 153(1):13–18
Naser IB, Hoque MM, Abdullah A, Bari SMN, Ghosh AN, Faruque SM (2017) Environmental bacteriophages active on biofilms and planktonic forms of toxigenic Vibrio cholerae: potential relevance in cholera epidemiology. PLoS One 12(7):e0180838. https://doi.org/10.1371/journal.pone.0180838
Nzakizwanayo J, Hanin A, Alves DR, McCutcheon B, Dedi C, Salvage J, Knox K, Stewart B, Metcalfe A, Clark J, Gilmore BF, Gahan CG, Jenkins AT, Jones BV (2015) Bacteriophage can prevent encrustation and blockage of urinary catheters by Proteus mirabilis. Antimicrob Agents Chemother 60(3):1530–1536. https://doi.org/10.1128/aac.02685-15
Oliveira A, Ribeiro HG, Silva AC, Silva MD, Sousa JC, Rodrigues CF, Melo LDR, Henriques AF, Sillankorva S (2017) Synergistic antimicrobial interaction between honey and phage against Escherichia coli biofilms. Front Microbiol 8:2407. https://doi.org/10.3389/fmicb.2017.02407
Oliveira A, Sousa JC, Silva AC, Melo LDR, Sillankorva S (2018) Chestnut honey and bacteriophage application to control Pseudomonas aeruginosa and Escherichia coli biofilms: evaluation in an ex vivo wound model. Front Microbiol 9:1725. https://doi.org/10.3389/fmicb.2018.01725
Pei R, Lamas-Samanamud GR (2014) Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol 80(17):5340–5348. https://doi.org/10.1128/AEM.01434-14
Pettit RK, Weber CA, Kean MJ, Hoffmann H, Pettit GR, Tan R, Franks KS, Horton ML (2005) Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing. Antimicrob Agents Chemother 49(7):2612–2617. https://doi.org/10.1128/AAC.49.7.2612-2617.2005
Pires DP, Melo LDR (2018) In vitro activity of bacteriophages against planktonic and biofilm populations assessed by flow cytometry. Methods Mol Biol 1693:33–41. https://doi.org/10.1007/978-1-4939-7395-8_4
Pires DP, Silva S, Almeida C, Henriques M, Anderson EM, Lam JS, Sillankorva S, Azeredo J (2013) Evaluation of the ability of C. albicans to form biofilm in the presence of phage-resistant phenotypes of P. aeruginosa. Biofouling 29(10):1169–1180. https://doi.org/10.1080/08927014.2013.831842
Pires DP, Oliveira H, Melo LD, Sillankorva S, Azeredo J (2016) Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl Microbiol Biotechnol 100(5):2141–2151. https://doi.org/10.1007/s00253-015-7247-0
Pires DP, Melo L, Vilas Boas D, Sillankorva S, Azeredo J (2017a) Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr Opin Microbiol 39:48–56. https://doi.org/10.1016/j.mib.2017.09.004
Pires DP, Dotsch A, Anderson EM, Hao Y, Khursigara CM, Lam JS, Sillankorva S, Azeredo J (2017b) A genotypic analysis of five P. aeruginosa strains after biofilm infection by phages targeting different cell surface receptors. Front Microbiol 8:1229. https://doi.org/10.3389/fmicb.2017.01229
Pitts B, Hamilton MA, Zelver N, Stewart PS (2003) A microtiter-plate screening method for biofilm disinfection and removal. J Microbiol Methods 54(2):269–276
Rahman M, Kim S, Kim SM, Seol SY, Kim J (2011) Characterization of induced Staphylococcus aureus bacteriophage SAP-26 and its anti-biofilm activity with rifampicin. Biofouling 27(10):1087–1093. https://doi.org/10.1080/08927014.2011.631169
Rumbaugh KP, Carty NL (2011) In vivo models of biofilm Infection. In: Bjarnsholt T, Jensen PØ, Moser C, Høiby N (eds) Biofilm infections. Springer, New York, pp 267–290. https://doi.org/10.1007/978-1-4419-6084-9_16
Ryan EM, Alkawareek MY, Donnelly RF, Gilmore BF (2012) Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro. FEMS Immunol Med Microbiol 65(2):395–398. https://doi.org/10.1111/j.1574-695X.2012.00977.x
Salisbury AM, Woo K, Sarkar S, Schultz G, Malone M, Mayer DO, Percival SL (2018) Tolerance of biofilms to antimicrobials and significance to antibiotic resistance in wounds. Surg Technol Int 33:59–66
Seth AK, Geringer MR, Nguyen KT, Agnew SP, Dumanian Z, Galiano RD, Leung KP, Mustoe TA, Hong SJ (2013) Bacteriophage therapy for Staphylococcus aureus biofilm-infected wounds: a new approach to chronic wound care. Plast Reconstr Surg 131(2):225–234. https://doi.org/10.1097/PRS.0b013e31827e47cd
Sillankorva S, Neubauer P, Azeredo J (2008) Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol 8:79. https://doi.org/10.1186/1472-6750-8-79
Singla S, Harjai K, Katare OP, Chhibber S (2016) Encapsulation of bacteriophage in liposome accentuates its entry in to macrophage and shields it from neutralizing antibodies. PLoS One 11(4):e0153777. https://doi.org/10.1371/journal.pone.0153777
Sonkar K, Purusottam RN, Sinha N (2012) Metabonomic study of host-phage interaction by nuclear magnetic resonance- and statistical total correlation spectroscopy-based analysis. Anal Chem 84(9):4063–4070. https://doi.org/10.1021/ac300096j
Torres-Barcelo C, Hochberg ME (2016) Evolutionary rationale for phages as complements of antibiotics. Trends Microbiol 24(4):249–256. https://doi.org/10.1016/j.tim.2015.12.011
Trivedi U, Madsen JS, Rumbaugh KP, Wolcott RD, Burmolle M, Sorensen SJ (2017) A post-planktonic era of in vitro infectious models: issues and changes addressed by a clinically relevant wound like media. Crit Rev Microbiol 43(4):453–465. https://doi.org/10.1080/1040841X.2016.1252312
Vandersteegen K, Kropinski AM, Nash JH, Noben JP, Hermans K, Lavigne R (2013) Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus genus, display suitable properties for phage therapy applications. J Virol 87(6):3237–3247. https://doi.org/10.1128/JVI.02763-12
Verma V, Harjai K, Chhibber S (2009) Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. J Antimicrob Chemother 64(6):1212–1218. https://doi.org/10.1093/jac/dkp360
Verma V, Harjai K, Chhibber S (2010) Structural changes induced by a lytic bacteriophage make ciprofloxacin effective against older biofilm of Klebsiella pneumoniae. Biofouling 26(6):729–737. https://doi.org/10.1080/08927014.2010.511196
Vilas Boas D, Almeida C, Sillankorva S, Nicolau A, Azeredo J, Azevedo NF (2016) Discrimination of bacteriophage infected cells using locked nucleic acid fluorescent in situ hybridization (LNA-FISH). Biofouling 32(2):179–190. https://doi.org/10.1080/08927014.2015.1131821
Waters EM, Neill DR, Kaman B, Sahota JS, Clokie MRJ, Winstanley C, Kadioglu A (2017) Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa. Thorax 72(7):666–667. https://doi.org/10.1136/thoraxjnl-2016-209265
Wright A, Hawkins CH, Anggard EE, Harper DR (2009) A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy. Clin Otolaryngol 34(4):349–357. https://doi.org/10.1111/j.1749-4486.2009.01973.x
Yilmaz C, Colak M, Yilmaz BC, Ersoz G, Kutateladze M, Gozlugol M (2013) Bacteriophage therapy in implant-related infections: an experimental study. J Bone Joint Surg Am 95(2):117–125. https://doi.org/10.2106/JBJS.K.01135
Zhang Y, Hu Z (2013) Combined treatment of Pseudomonas aeruginosa biofilms with bacteriophages and chlorine. Biotechnol Bioeng 110(1):286–295. https://doi.org/10.1002/bit.24630
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Melo, L.D.R., Pires, D.P., Monteiro, R., Azeredo, J. (2019). Phage Therapy of Infectious Biofilms: Challenges and Strategies. In: Górski, A., Międzybrodzki, R., Borysowski, J. (eds) Phage Therapy: A Practical Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-26736-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-26736-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-26735-3
Online ISBN: 978-3-030-26736-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)